New pharmaceutical compounds

TW202641510APending Publication Date: 2026-10-16ORION CORP(FI)
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW114148618
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2024-12-20
Filing Date
2025-12-11
Publication Date
2026-10-16
Patent Text Reader

Abstract

The disclosure relates to compounds of formula I, wherein A, B, and R1 have the meaning given in the specification, and pharmaceutically acceptable salts thereof. The compounds of formula (I) exhibit GPR183 antagonistic activity and are thus useful in the treatment or prevention of disorder, condition, or disease where GRP183 antagonist is indicated to be useful.
Need to check novelty before this filing date? Find Prior Art